In Vitro Activity of the New Triazole Voriconazole (UK-109,496) against Opportunistic Filamentous and Dimorphic Fungi and Common and Emerging Yeast Pathogens

Benzer Materyaller

• Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts
  Yazar:: Espinel-Ingroff, Ana
  Baskı/Yayın Bilgisi: (1998)
• In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species.
  Yazar:: Barry, A L, ve diğerleri
  Baskı/Yayın Bilgisi: (1996)
• A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
  Yazar:: Sanati, H, ve diğerleri
  Baskı/Yayın Bilgisi: (1997)
• Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs.
  Yazar:: Martin, M V, ve diğerleri
  Baskı/Yayın Bilgisi: (1997)
• Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida species.
  Yazar:: Belanger, P, ve diğerleri
  Baskı/Yayın Bilgisi: (1997)